Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Clinical significance of periodic detection of hepatitis B virus YVDD mutation by ultrasensitive real-time amplification refractory mutation system quantitative PCR during lamivudine treatment in patients with chronic hepatitis B

Published:2015-03-01 Issue:3 Volume:64 Page:237-242
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Zeng Yongbin¹²,Yang Bin¹²,Wu Yingying¹²,Chen Jing³²,Shang Hongyan¹²,Chen Xiao¹²,Su Mingkuan¹²,Wu Songhang¹²,Lin Jinpiao¹²,Ou Qishui¹²

Affiliation:

1. Department of Gene Diagnosis, Fujian Medical University, Fuzhou, PR China

2. Department of Laboratory Medicine, The First Affiliated Hospital of Fujian Medical University, Fuzhou, PR China

3. Center of Liver Diseases, The First Affiliated Hospital of Fujian Medical University, Fuzhou, PR China

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference18 articles.

1. YMDD motif variants in inactive hepatitis B carriers detected by Inno-Lipa HBV DR assay

2. The influence of hepatitis B virus genotype on the development of lamivudine resistance during long-term treatment

3. Is hepatitis B virus subtype testing useful in predicting virological response and resistance to lamivudine?

4. Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B

5. Early changes of hepatitis B virus quasispecies during lamivudine treatment and the correlation with antiviral efficacy

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern;Microbiology Spectrum;2022-02-23

2. Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients;Clinica Chimica Acta;2020-03